De-escalation of Axillary Surgery in Inflammatory Breast Cancer: The Right Time is Coming
Status Publisher Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu úvodníky
Grantová podpora
long-term institutional support for research activ
Slezská Univerzita v Opavě
MMCI
MH CZ - DRO
00209805
MH CZ - DRO
PubMed
40954395
DOI
10.1245/s10434-025-18356-9
PII: 10.1245/s10434-025-18356-9
Knihovny.cz E-zdroje
- Klíčová slova
- Axillary surgery, De-escalation, Inflammatory breast cancer, Targeted axillary dissection, Targeted lymph node dissection,
- Publikační typ
- úvodníky MeSH
Department of Surgery Silesian Hospital in Opava Opava Czech Republic
Department of Surgical Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Surgical Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Zobrazit více v PubMed
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th edn. London: Wiley-Blackwell; 2016.
Güth U, Jane Huang D, Holzgreve W, Wight E, Singer G. T4 breast cancer under closer inspection: a case for revision of the TNM classification. Breast. 2007;16(6):625–36. https://doi.org/10.1016/j.breast.2007.05.006 . PubMed DOI
Boughey JC. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. JAMA. 2013;310(14):1455–61. https://doi.org/10.1001/jama.2013.278932 . PubMed DOI PMC
Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–18. https://doi.org/10.1016/S1470-2045(13)70166-9 . PubMed DOI
Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients. Ann Surg. 2015;261(2):378–82. https://doi.org/10.1097/SLA.0000000000000558 . PubMed DOI
Fayanju OM, Ren Y, Greenup RA, et al. Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients. Breast Cancer Res Treat. 2020;180(1):207–17. https://doi.org/10.1007/s10549-020-05529-1 . PubMed DOI PMC
Zapletal O, Žatecký J, Gabrielová L, et al. Axillary overtreatment in patients with breast cancer after neoadjuvant chemotherapy in the current era of targeted axillary dissection. Cancers. 2025;17(2):178. https://doi.org/10.3390/cancers17020178 . PubMed DOI PMC
Mamounas EP, Bandos H, White JR, et al. Omitting regional nodal irradiation after response to neoadjuvant chemotherapy. N Engl J Med. 2025;392(21):2113–24. https://doi.org/10.1056/nejmoa2414859 . PubMed DOI PMC
DeSnyder SM, Mittendorf EA, Le-Petross C, et al. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer. 2018;18(1):e73–7. https://doi.org/10.1016/j.clbc.2017.06.014 . PubMed DOI
Karanlik H, Cabioglu N, Oprea AL, et al. Sentinel lymph node biopsy may prevent unnecessary axillary dissection in patients with inflammatory breast cancer who respond to systemic treatment. Breast Care. 2021;16(5):468–74. https://doi.org/10.1159/000512202 . PubMed DOI
Lohani KR, Hoskin TL, Yasir S, et al. Clipped axillary node as a potential surrogate for overall axillary nodal status in inflammatory breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol. 2024;31(11):7431–40. https://doi.org/10.1245/s10434-024-15796-7 . PubMed DOI PMC
Heidinger M, Knauer M, Tausch C, Weber WP. Tailored axillary surgery—a novel concept for clinically node positive breast cancer. Breast. 2023;69:281–9. https://doi.org/10.1016/j.breast.2023.03.005 . PubMed DOI PMC
